Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing

Diabetic ischemic wound treatment remains a critical clinical challenge. Neovascularization plays a significant role in wound healing during all stages of the tissue repair process. Strategies that enhance angiogenesis and neovascularization and improve ischemic pathology may promote the healing of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siqi He, Tanaya Walimbe, Hongyuan Chen, Kewa Gao, Priyadarsini Kumar, Yifan Wei, Dake Hao, Ruiwu Liu, Diana L. Farmer, Kit S. Lam, Jianda Zhou, Alyssa Panitch, Aijun Wang
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2022
Materias:
Acceso en línea:https://doaj.org/article/e0cf9bdd9cf540b48f856c8d765dacfb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e0cf9bdd9cf540b48f856c8d765dacfb
record_format dspace
spelling oai:doaj.org-article:e0cf9bdd9cf540b48f856c8d765dacfb2021-11-28T04:35:11ZBioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing2452-199X10.1016/j.bioactmat.2021.08.017https://doaj.org/article/e0cf9bdd9cf540b48f856c8d765dacfb2022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452199X21003935https://doaj.org/toc/2452-199XDiabetic ischemic wound treatment remains a critical clinical challenge. Neovascularization plays a significant role in wound healing during all stages of the tissue repair process. Strategies that enhance angiogenesis and neovascularization and improve ischemic pathology may promote the healing of poor wounds, particularly diabetic wounds in highly ischemic conditions. We previously identified a cyclic peptide LXW7 that specifically binds to integrin αvβ3 on endothelial progenitor cells (EPCs) and endothelial cells (ECs), activates vascular endothelial growth factor (VEGF) receptors, and promotes EC growth and maturation. In this study, we designed and synthesized a multi-functional pro-angiogenic molecule by grafting LXW7 and collagen-binding peptides (SILY) to a dermatan sulfate (DS) glycosaminoglycan backbone, named LXW7-DS-SILY, and further employed this multi-functional molecule to functionalize collagen-based extracellular matrix (ECM) scaffolds. We confirmed that LXW7-DS-SILY modification significantly promoted EPC attachment and growth on the ECM scaffolds in vitro and supported EPC survival in vivo in the ischemic environment. When applied in an established Zucker Diabetic Fatty (ZDF) rat ischemic skin flap model, LXW7-DS-SILY-functionalized ECM scaffolds loaded with EPCs significantly improved wound healing, enhanced neovascularization and modulated collagen fibrillogenesis in the ischemic environment. Altogether, this study provides a promising novel treatment to accelerate diabetic ischemic wound healing, thereby reducing limb amputation and mortality of diabetic patients.Siqi HeTanaya WalimbeHongyuan ChenKewa GaoPriyadarsini KumarYifan WeiDake HaoRuiwu LiuDiana L. FarmerKit S. LamJianda ZhouAlyssa PanitchAijun WangKeAi Communications Co., Ltd.articleDiabetic ischemic woundECM scaffoldEndothelial progenitor cellsNeovascularizationWound healingMaterials of engineering and construction. Mechanics of materialsTA401-492Biology (General)QH301-705.5ENBioactive Materials, Vol 10, Iss , Pp 460-473 (2022)
institution DOAJ
collection DOAJ
language EN
topic Diabetic ischemic wound
ECM scaffold
Endothelial progenitor cells
Neovascularization
Wound healing
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
spellingShingle Diabetic ischemic wound
ECM scaffold
Endothelial progenitor cells
Neovascularization
Wound healing
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
Siqi He
Tanaya Walimbe
Hongyuan Chen
Kewa Gao
Priyadarsini Kumar
Yifan Wei
Dake Hao
Ruiwu Liu
Diana L. Farmer
Kit S. Lam
Jianda Zhou
Alyssa Panitch
Aijun Wang
Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
description Diabetic ischemic wound treatment remains a critical clinical challenge. Neovascularization plays a significant role in wound healing during all stages of the tissue repair process. Strategies that enhance angiogenesis and neovascularization and improve ischemic pathology may promote the healing of poor wounds, particularly diabetic wounds in highly ischemic conditions. We previously identified a cyclic peptide LXW7 that specifically binds to integrin αvβ3 on endothelial progenitor cells (EPCs) and endothelial cells (ECs), activates vascular endothelial growth factor (VEGF) receptors, and promotes EC growth and maturation. In this study, we designed and synthesized a multi-functional pro-angiogenic molecule by grafting LXW7 and collagen-binding peptides (SILY) to a dermatan sulfate (DS) glycosaminoglycan backbone, named LXW7-DS-SILY, and further employed this multi-functional molecule to functionalize collagen-based extracellular matrix (ECM) scaffolds. We confirmed that LXW7-DS-SILY modification significantly promoted EPC attachment and growth on the ECM scaffolds in vitro and supported EPC survival in vivo in the ischemic environment. When applied in an established Zucker Diabetic Fatty (ZDF) rat ischemic skin flap model, LXW7-DS-SILY-functionalized ECM scaffolds loaded with EPCs significantly improved wound healing, enhanced neovascularization and modulated collagen fibrillogenesis in the ischemic environment. Altogether, this study provides a promising novel treatment to accelerate diabetic ischemic wound healing, thereby reducing limb amputation and mortality of diabetic patients.
format article
author Siqi He
Tanaya Walimbe
Hongyuan Chen
Kewa Gao
Priyadarsini Kumar
Yifan Wei
Dake Hao
Ruiwu Liu
Diana L. Farmer
Kit S. Lam
Jianda Zhou
Alyssa Panitch
Aijun Wang
author_facet Siqi He
Tanaya Walimbe
Hongyuan Chen
Kewa Gao
Priyadarsini Kumar
Yifan Wei
Dake Hao
Ruiwu Liu
Diana L. Farmer
Kit S. Lam
Jianda Zhou
Alyssa Panitch
Aijun Wang
author_sort Siqi He
title Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
title_short Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
title_full Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
title_fullStr Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
title_full_unstemmed Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
title_sort bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
publisher KeAi Communications Co., Ltd.
publishDate 2022
url https://doaj.org/article/e0cf9bdd9cf540b48f856c8d765dacfb
work_keys_str_mv AT siqihe bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT tanayawalimbe bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT hongyuanchen bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT kewagao bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT priyadarsinikumar bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT yifanwei bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT dakehao bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT ruiwuliu bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT dianalfarmer bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT kitslam bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT jiandazhou bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT alyssapanitch bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
AT aijunwang bioactiveextracellularmatrixscaffoldsengineeredwithproangiogenicproteoglycanmimeticsandloadedwithendothelialprogenitorcellspromoteneovascularizationanddiabeticwoundhealing
_version_ 1718408351860129792